Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGetbusy Regulatory News (GETB)

Share Price Information for Getbusy (GETB)

Share Price is delayed by 15 minutes
Get Live Data
71.50    0.00 (0.00%)
Bid:
70.00
Ask:
73.00
Spread: 3.00 (4.286%)
Market Cap: £36.24m
GETB Live PriceLast checked at - London Stock Exchange

Intraday Getbusy Share Chart

COVID-19 Update

22 Apr 2020 07:00

RNS Number : 4041K
GetBusy PLC
22 April 2020
 

22 April 2020

GetBusy plc

("GetBusy" or "the Company" or "the Group)

COVID-19 Update

GetBusy plc (AIM: GETB), a leading developer of document management and productivity software products, provides the following update in light of the current COVID-19 pandemic.

COVID-19 Update

Firstly, we are very pleased that none of our team has been diagnosed with COVID-19; the health and wellbeing of our people is paramount. We transitioned to working from home from mid-March and the team has adapted impressively; the fact that nearly all our business tools are cloud-based ensured this process went smoothly.

We are fortunate that our subscription business model is inherently resilient to the challenges that many businesses are currently facing. Whilst we naturally expect disruption to the appetite of some prospective customers to adopt new technology at this time, we regard the current international lockdown as a catalyst that potentially accelerates the trends of remote and digital working that are helpful to our business in the medium and long term.

Receipt of loan under US Paycheck Protection Program

The Company also announces the receipt of a US$ 515,000 loan under the US Small Business Administration's Paycheck Protection Program ("PPP") by the Group's US trading subsidiary, GetBusy USA Corporation.

The PPP is a component of the US federal stimulus package known as the Coronavirus Aid, Relief and Economic Security Act ("CARES"), which offers help to small businesses in the US during the COVID-19 crisis. Under PPP, the loan, or a proportion of it, may be forgivable if the use of the proceeds meets certain criteria, including retaining US employees. We anticipate meeting these criteria and expect between 90% and 100% of the loan to be forgiven over the next eight weeks. Any forgiven portion of the loan will be recorded in the Group's income statement as Other Income, which is excluded from Adjusted Profit / (Loss), our principal measure of Group financial performance. The loan forgiveness is not taxable.

A more detailed update on trading will be provided in advance of the Company's AGM on 5 May 2020.

Enquiries

GetBusy plc

Daniel Rabie (Chief Executive Officer)

investors@getbusy.com

Paul Haworth (Chief Financial Officer)

Liberum (Nomad and Broker)

Bidhi Bhoma / Cameron Duncan / Louis Davies

+44 (0)20 3100 2000

 

About GetBusy

GetBusy is a global Document Management and Communication software business that provides highly secure forms of digital document distribution, workflows and client chat. 1.6 million users are now registered to share information through GetBusy's award-winning online client portals.

Further information on the Group is available at www.getbusy.com/about/investors

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCDZGZDKMVGGZM
Date   Source Headline
13th May 202610:03 amRNSResult of AGM
13th May 20267:00 amRNSAGM Trading Update
20th Apr 20267:00 amRNSAnnual Report and Notice of AGM
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNS2025 Audited Results
21st Jan 20267:00 amRNSTrading Update
2nd Dec 20259:48 amRNSHolding(s) in Company
1st Dec 202510:23 amRNSDirector/PDMR Shareholding
4th Nov 202511:00 amRNSHolding(s) in Company
15th Oct 20257:00 amRNSIntegration with Intuit ProConnect Tax
13th Oct 20256:08 pmRNSDirector/PDMR Shareholding - Replacement
13th Oct 20256:05 pmRNSDirector/PDMR Shareholding - Replacement
13th Oct 20256:02 pmRNSDirector/PDMR Shareholding - Replacement
10th Oct 202511:28 amRNSHolding(s) in Company
9th Oct 20254:00 pmRNSDirector/PDMR Shareholding
7th Oct 20254:07 pmRNSHolding(s) in Company
6th Oct 20252:30 pmRNSDirector/PDMR Shareholding
3rd Oct 20254:56 pmRNSDirector/PDMR Shareholding
3rd Oct 20254:50 pmRNSDirector/PDMR Shareholding
29th Sep 20259:45 amRNSDirector/PDMR Shareholding
22nd Sep 202511:31 amRNSDirector/PDMR Shareholding
19th Sep 20254:41 pmRNSDirector/PDMR Shareholding
12th Sep 20252:11 pmRNSDirector/PDMR Shareholding
12th Sep 202510:11 amRNSDirector/PDMR Shareholding
9th Sep 20257:00 amRNS2025 Half-year Results
4th Aug 20257:00 amRNSChanges to Concert Party & Notice of Results
20th May 202512:02 pmRNSResult of AGM
20th May 20257:00 amRNSAGM Trading Update
14th May 202511:01 amRNSDirector/PDMR Shareholding
7th May 20259:01 amRNSDirector/PDMR Shareholding
30th Apr 20257:00 amRNSNotice of AGM
25th Mar 20257:00 amRNS2024 Audited Results
23rd Jan 20257:00 amRNSTrading Update
7th Nov 20241:14 pmRNSHolding(s) in Company
7th Nov 202410:30 amRNSHolding(s) in Company
15th Oct 20241:22 pmRNSDirector/PDMR Shareholding
13th Sep 202412:34 pmRNSExercise of Options and Total Voting Rights
3rd Sep 20247:00 amRNS2024 Half-year Results
29th Aug 20249:40 amRNSInvestor Presentation via Investor Meet Company
24th Jul 20247:00 amRNSNotice of Results
16th Jul 20244:23 pmRNSHolding(s) in Company
3rd Jun 202411:45 amRNSDirector/PDMR Shareholding
3rd Jun 20249:00 amRNSDirector/PDMR Shareholding
24th May 202410:26 amRNSDirector/PDMR Shareholding
21st May 202412:15 pmRNSResult of AGM
21st May 20247:00 amRNSAGM Trading Update
29th Apr 20247:00 amRNSAnnual Report and Notice of Annual General Meeting
4th Apr 20247:00 amRNSAcquisition of SmartPath
26th Mar 20247:00 amRNS2023 Audited Results
15th Mar 20247:00 amRNSInvestor Presentation via Investor Meet Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.